Diseases

In this presentation and discussion moderated by Whitehead Institute Member Pulin Li, hear what Whitehead Fellows Silvia Rouskin and Kipp Weiskopf are learning about SARS-CoV-2 — and how their research may aid in the fight against dangerous coronaviruses, now and well into the future.

Researchers in the lab of Whitehead Institute Founding Member Robert Weinberg have determined how mesenchymal cancer cells may resist treatment, work that may allow them to make once-resistant tumors respond to certain cancer therapies.

On this episode of AudioHelicase podcast, Whitehead Fellow Olivia Corradin talked about investigating the genetic underpinnings of diseases through a new technique she developed, the outside variant approach. Applying the method to study the autoimmune disease multiple sclerosis (MS), Corradin and colleagues identified a role for a cell type in the brain in MS, offering a new way of understanding the disease. 

Xin Tang is a postdoc in Whitehead Institute Member Rudolf Jaenisch’s lab investigating brain disease and developing approaches to discover new therapies. We sat down with Tang to learn more about him and his experiences in and out of the lab.